Memphasys Ltd (AU:MEM) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Memphasys Ltd has received an order from a Dubai clinic for its innovative Felix™ System, marking a strategic step into the Middle Eastern market. This order will assess the system’s suitability for research in the UAE’s regulatory framework, potentially paving the way for expansion in the rapidly growing IVF sector. The initiative aligns with Dubai’s status as a leading destination for medical tourism, particularly in fertility treatments.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.